JP2025081638A5 - - Google Patents

Info

Publication number
JP2025081638A5
JP2025081638A5 JP2025028474A JP2025028474A JP2025081638A5 JP 2025081638 A5 JP2025081638 A5 JP 2025081638A5 JP 2025028474 A JP2025028474 A JP 2025028474A JP 2025028474 A JP2025028474 A JP 2025028474A JP 2025081638 A5 JP2025081638 A5 JP 2025081638A5
Authority
JP
Japan
Prior art keywords
seq
antibody
mgs
composition
targets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025028474A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025081638A (ja
Filing date
Publication date
Priority claimed from JP2020501210A external-priority patent/JP7289029B2/ja
Application filed filed Critical
Publication of JP2025081638A publication Critical patent/JP2025081638A/ja
Publication of JP2025081638A5 publication Critical patent/JP2025081638A5/ja
Pending legal-status Critical Current

Links

JP2025028474A 2017-07-10 2025-02-26 分子誘導システムペプチド及びその使用 Pending JP2025081638A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762530633P 2017-07-10 2017-07-10
US62/530,633 2017-07-10
JP2020501210A JP7289029B2 (ja) 2017-07-10 2018-07-10 分子誘導システムペプチド及びその使用
PCT/US2018/041403 WO2019014190A1 (en) 2017-07-10 2018-07-10 MOLECULAR GUIDANCE SYSTEM PEPTIDES AND USES THEREOF
JP2023062195A JP7642700B2 (ja) 2017-07-10 2023-04-06 分子誘導システムペプチド及びその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023062195A Division JP7642700B2 (ja) 2017-07-10 2023-04-06 分子誘導システムペプチド及びその使用

Publications (2)

Publication Number Publication Date
JP2025081638A JP2025081638A (ja) 2025-05-27
JP2025081638A5 true JP2025081638A5 (https=) 2026-01-30

Family

ID=65002631

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020501210A Active JP7289029B2 (ja) 2017-07-10 2018-07-10 分子誘導システムペプチド及びその使用
JP2023062195A Active JP7642700B2 (ja) 2017-07-10 2023-04-06 分子誘導システムペプチド及びその使用
JP2025028474A Pending JP2025081638A (ja) 2017-07-10 2025-02-26 分子誘導システムペプチド及びその使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2020501210A Active JP7289029B2 (ja) 2017-07-10 2018-07-10 分子誘導システムペプチド及びその使用
JP2023062195A Active JP7642700B2 (ja) 2017-07-10 2023-04-06 分子誘導システムペプチド及びその使用

Country Status (6)

Country Link
US (3) US11965004B2 (https=)
EP (1) EP3652196A4 (https=)
JP (3) JP7289029B2 (https=)
CN (2) CN111278847B (https=)
AU (3) AU2018301804B2 (https=)
WO (1) WO2019014190A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3652196A4 (en) 2017-07-10 2021-08-18 Brown, Kathlynn, C. MOLECULAR GUIDANCE SYSTEMPEPTIDES AND USES THEREOF
JP2020527556A (ja) 2017-07-10 2020-09-10 エスアールアイ インターナショナルＳＲＩ Ｉｎｔｅｒｎａｔｉｏｎａｌ がん治療用ペプチドサポリン複合体
AU2020357455B2 (en) * 2019-10-01 2026-04-09 Sri International Molecular guide system peptides and uses thereof
EP4199907A4 (en) * 2020-09-21 2024-10-09 SRI International Targeted antigen delivery system and uses thereof
WO2025106488A1 (en) * 2023-11-13 2025-05-22 Sri International Lung fibroblast-specific molecular guidance system peptides and uses thereof
CN118440159A (zh) * 2024-04-28 2024-08-06 中国人民解放军海军军医大学第二附属医院 一种预防或治疗心肌缺血再灌注损伤的多肽及其应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7671010B2 (en) 2002-08-30 2010-03-02 The Board Of Regents Of The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
AU2003251751A1 (en) * 2002-06-28 2004-01-19 The Johns Hopkins University Agents capable of inhibiting ras and uses thereof
EP1565495A2 (en) * 2002-11-15 2005-08-24 Medical Research Council Anti-activated ras antibodies
PL2382990T3 (pl) 2003-04-30 2015-04-30 Univ Zuerich Sposoby leczenia raka z zastosowaniem immunotoksyny
EP1718323B1 (en) 2004-02-20 2011-12-07 The Trustees of The University of Pennsylvania Binding peptidomimetics and uses of the same
EP1867661A1 (en) * 2006-06-12 2007-12-19 Diatos Compositions and methods for delivering anti-activated ras antibodies into cells
JP2010526091A (ja) * 2007-04-30 2010-07-29 インテザイン テクノロジーズ， インコーポレイテッド 癌の処置のための生物学的な標的基の改変
WO2009089186A2 (en) 2008-01-05 2009-07-16 Sloan-Kettering Institute For Cancer Research Peptide-conjugated oligonucleotide therapeutic and method of making and using same
EP2352522A4 (en) * 2008-11-06 2014-03-05 Univ Washington BISPECIFIC AUXILIARIES FOR INTRA-CELLULAR RELEASE
US8241623B1 (en) * 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
US8481678B2 (en) * 2009-03-30 2013-07-09 E I Du Pont De Nemours And Company Peptide-based tooth whitening reagents
CN101724073A (zh) * 2010-01-19 2010-06-09 成都军区昆明总医院 一种广谱抗ras基因表达蛋白的单克隆抗体及其制备方法
US8524220B1 (en) * 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US8362207B2 (en) * 2010-04-16 2013-01-29 Wake Forest University Health Sciences Multi-level specific targeting of cancer cells with IL-13
WO2012040513A1 (en) * 2010-09-22 2012-03-29 The Board Of Regents Of The University Of Texas System Compositions and methods for the delivery of beta lapachone
BR112013010911A2 (pt) * 2010-11-01 2017-05-02 Peptimed Inc composições de um sistema à base de peptídeo para direcionamento para céllas específicas
US8515001B2 (en) * 2010-12-24 2013-08-20 Lg Display Co., Ltd. Shift register
EP2476441A1 (en) 2011-01-13 2012-07-18 Universitat Autònoma De Barcelona Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
US20120283410A1 (en) * 2011-03-14 2012-11-08 Intezyne Technologies, Incorporated Attachment of biological targeting groups using metal free click chemistry
US9062312B2 (en) * 2011-06-21 2015-06-23 Danisco Us Inc. Fusion peptides comprising multi-functional peptidic solubility tags for efficient production, processing and surface applications
US9572898B2 (en) * 2013-09-09 2017-02-21 Seton Hall University Functionalized fluorine containing phthalocyanine molecules
GB201318954D0 (en) * 2013-10-28 2013-12-11 Cupid Peptide Company Ltd Cell transport
US9382540B2 (en) 2014-05-01 2016-07-05 Isis Pharmaceuticals, Inc Compositions and methods for modulating angiopoietin-like 3 expression
WO2016022597A1 (en) 2014-08-04 2016-02-11 Case Western Reserve University Targeting peptides and methods of use
CN107223051B (zh) 2014-12-17 2021-09-03 斯坦福国际研究院 抗原递送系统
US20180157388A1 (en) 2016-12-02 2018-06-07 Google Inc. Emotion expression in virtual environment
US12059472B2 (en) 2016-12-21 2024-08-13 Bayer Aktiengesellschaft Prodrugs of cytotoxic active agents having enzymatically cleavable groups
EP3652196A4 (en) 2017-07-10 2021-08-18 Brown, Kathlynn, C. MOLECULAR GUIDANCE SYSTEMPEPTIDES AND USES THEREOF
JP2020527556A (ja) 2017-07-10 2020-09-10 エスアールアイ インターナショナルＳＲＩ Ｉｎｔｅｒｎａｔｉｏｎａｌ がん治療用ペプチドサポリン複合体

Similar Documents

Publication Publication Date Title
JP2025081638A5 (https=)
Varner et al. Recent advances in engineering polyvalent biological interactions
Lee et al. Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo
US20080166293A1 (en) Receptor-mediated uptake of peptides that bind the human transferrin receptor
Sung et al. The importance of valency in enhancing the import and cell routing potential of protein transduction domain-containing molecules
US12441774B2 (en) Molecular guide system peptides and uses thereof
Weber et al. Concentration-independent multivalent targeting of Cancer cells by genetically encoded Core-crosslinked elastin/Resilin-like polypeptide micelles
US20190022240A1 (en) Design of pH-Sensitive Oligopeptide Complexes For Drug Release Under Mildly Acidic Conditions
JP2003530360A (ja) 薬剤送達のためのペプチド複合体
JP2025166082A (ja) 分子ガイドシステムペプチド及びその使用
Benavent Acero et al. Mechanisms of cellular uptake, intracellular transportation, and degradation of CIGB-300, a Tat-conjugated peptide, in tumor cell lines
JP2003504417A (ja) 活性物質の細胞特異的、区画特異的、または膜特異的輸送媒介用コンジュゲート
Killian et al. Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids
Zhang et al. Polyarginine-mediated siRNA delivery: a mechanistic study of intracellular trafficking of PCL-R15/siRNA nanoplexes
US8415306B2 (en) Insulin-like growth factor 1 receptor binding peptides
Maity et al. Intrinsically disordered Ku protein-derived cell-penetrating peptides
Reissmann State of art: Cell penetration and cell-penetrating peptides and proteins
US12312386B2 (en) Targeted intracellular delivery of large nucleic acids
US20100266592A1 (en) Therapeutic antennapedia-antibody molecules and methods of use thereof
US20170037091A1 (en) Sty peptides for inhibition of angiogenesis
Kim et al. Cell-penetrating peptides for therapeutic applications: emerging design strategies and future directions
Budda et al. MECHANISMS OF DRUG ENTRY INTO NUCLEUS
HK40043200A (en) Targeted intracellular delivery of large nucleic acids